Toll Free: 1-888-928-9744

Male Hypogonadism Global Clinical Trials Review, H1, 2016

Published: Mar 31, 2016 | Pages: 233 | Publisher: GlobalData | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Male Hypogonadism Global Clinical Trials Review, H1, 2016

Summary

GlobalData's clinical trial report, 
 Table of Contents
1 Table of Contents 2 List of Tables 3 List of Figures 4 Report Guidance 5 Clinical Trials by Region 6 Clinical Trials and Average Enrollment by Country 7 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10 Top Five Countries Contributing to Clinical Trials in Europe 11 Top Countries Contributing to Clinical Trials in North America 12 Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13 Top Countries Contributing to Clinical Trials in Central and South America 14 Clinical Trials by G7 Countries: Proportion of Male Hypogonadism to Male Health Clinical Trials 15 Clinical Trials by Phase in G7 Countries 16 Clinical Trials in G7 Countries by Trial Status 17 Clinical Trials by E7 Countries: Proportion of Male Hypogonadism to Male Health Clinical Trials 18 Clinical Trials by Phase in E7 Countries 19 Clinical Trials in E7 Countries by Trial Status 20 Clinical Trials by Phase 21 In Progress Trials by Phase 22 Clinical Trials by Trial Status 23 Clinical Trials by End Point Status 24 Subjects Recruited Over a Period of Time 25 Clinical Trials by Sponsor Type 26 Prominent Sponsors 27 Top Companies Participating in Male Hypogonadism Therapeutics Clinical Trials 28 Prominent Drugs 30 Latest Clinical Trials News on Male Hypogonadism 31 Mar 28, 2016: Lipocine Announces the Presentation of Clinical Data for LPCN 1021, Its Oral Testosterone Replacement Therapy Product Candidate, at the American Society of Andrology 41st Annual Conference 31 Mar 28, 2016: Lipocine Announces the Presentation of Clinical Data for LPCN 1021, Its Oral Testosterone Replacement Therapy Product Candidate, at ENDO 2016 31 Mar 16, 2016: Antares Pharma Announces Completion of the 52 Week QuickShot Phase 3 Study in Testosterone Deficient Men 31 Feb 17, 2016: New Research Finds Testosterone Treatment Improves Sexual Activity, Physical Function in Men Over 65 Years Old 32 Jan 04, 2016: Acerus Announces NATESTO Publication in Prominent Andrology Journal 33 Jan 04, 2016: Lipocine Announces First Patient Dosed in Phase 2B Clinical Study for LPCN 1111, a Novel Testosterone Replacement Therapy 33 Clinical Trial Profile Snapshots 35 Appendix 230 Abbreviations 230 Definitions 230 Research Methodology 231 Secondary Research 231 About GlobalData 232 Contact Us 232 Disclaimer 232 Source 233
List of Tables
Male Hypogonadism Therapeutics, Global, Clinical Trials by Region, 2016* 6 Male Hypogonadism Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8 Male Hypogonadism Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9 Male Hypogonadism Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 10 Male Hypogonadism Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11 Male Hypogonadism Therapeutics Clinical Trials, North America, Top Countries, 2016* 12 Male Hypogonadism Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 13 Male Hypogonadism Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 14 Proportion of Male Hypogonadism to Male Health Clinical Trials, G7 Countries (%), 2016* 15 Male Hypogonadism Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16 Male Hypogonadism Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17 Proportion of Male Hypogonadism to Male Health Clinical Trials, E7 Countries (%), 2016* 18 Male Hypogonadism Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19 Male Hypogonadism Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20 Male Hypogonadism Therapeutics, Global, Clinical Trials by Phase, 2016* 21 Male Hypogonadism Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 22 Male Hypogonadism Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23 Male Hypogonadism Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24 Male Hypogonadism Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25 Male Hypogonadism Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 26 Male Hypogonadism Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27 Male Hypogonadism Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 29 Male Hypogonadism Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30


List of Figures
Male Hypogonadism Therapeutics, Global, Clinical Trials by Region (%), 2016* 6 Male Hypogonadism Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Male Hypogonadism Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9 Male Hypogonadism Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 10 Male Hypogonadism Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11 Male Hypogonadism Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12 Male Hypogonadism Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 13 Male Hypogonadism Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2016* 14 Proportion of Male Hypogonadism to Male Health Clinical Trials, G7 Countries (%), 2016* 15 Male Hypogonadism Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16 Male Hypogonadism Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17 Proportion of Male Hypogonadism to Male Health Clinical Trials, E7 Countries (%), 2016* 18 Male Hypogonadism Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19 Male Hypogonadism Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20 Male Hypogonadism Therapeutics, Global, Clinical Trials by Phase (%), 2016* 21 Male Hypogonadism Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 22 Male Hypogonadism Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23 Male Hypogonadism Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24 Male Hypogonadism Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25 Male Hypogonadism Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 26 Male Hypogonadism Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27 Male Hypogonadism Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28 Male Hypogonadism Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30 GlobalData Methodology 231

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global electric water heaters market is expected to be valued at USD 29,322.4 million by 2022, as per a new research report by Radiant Insights, Inc. Escalating demand across extensive range of domestic applications is expected to drive demand. Evolv

Read More...

Global polymethyl methacrylate (PMMA) market size is likely to be valued at USD 11.65 billion by 2022; as per a new research report by Radiant Insights, Inc. Increasing spending on advertising & marketing for building strong brand equity and product

Read More...

Global adhesives & sealants market size is expected to reach USD 43.19 billion by 2020, as per a new research report by Radiant Insights, Inc. Strong demand from packaging, construction and automotive industries is expected drive adhesives and sealan

Read More...

Global gas sensors market is expected to reach USD 2,512.4 million by 2020, as per a new research report by Radiant Insights, Inc. High adoption rate of wireless and smart gas sensor technology coupled with escalating demand from end-use industries s

Read More...

Global fluorotelomers market size is anticipated to be valued at USD 539.3 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing application scope in fire fighting systems owing to growing safety concerns is likely to dri

Read More...
Choose License Type
Single User - US $2500
Multi User - US $5000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify